Los Angeles Capital Management LLC Buys 23,160 Shares of Accuray Incorporated (NASDAQ:ARAY)

Los Angeles Capital Management LLC boosted its stake in shares of Accuray Incorporated (NASDAQ:ARAY) by 10.0% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 255,378 shares of the medical equipment provider’s stock after acquiring an additional 23,160 shares during the period. Los Angeles Capital Management LLC’s holdings in Accuray were worth $506,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently added to or reduced their stakes in ARAY. SG Americas Securities LLC lifted its position in shares of Accuray by 37.4% during the 4th quarter. SG Americas Securities LLC now owns 45,079 shares of the medical equipment provider’s stock valued at $89,000 after acquiring an additional 12,259 shares during the period. Assenagon Asset Management S.A. raised its stake in Accuray by 28.7% in the fourth quarter. Assenagon Asset Management S.A. now owns 212,330 shares of the medical equipment provider’s stock valued at $420,000 after purchasing an additional 47,331 shares in the last quarter. Virtu Financial LLC bought a new stake in Accuray during the third quarter worth about $244,000. Barclays PLC grew its stake in Accuray by 97.9% during the third quarter. Barclays PLC now owns 210,819 shares of the medical equipment provider’s stock worth $380,000 after buying an additional 104,310 shares in the last quarter. Finally, Geode Capital Management LLC increased its holdings in Accuray by 2.1% in the 3rd quarter. Geode Capital Management LLC now owns 2,179,396 shares of the medical equipment provider’s stock valued at $3,924,000 after buying an additional 45,548 shares during the period. Institutional investors own 64.08% of the company’s stock.

Analyst Upgrades and Downgrades

Separately, StockNews.com downgraded shares of Accuray from a “buy” rating to a “hold” rating in a report on Tuesday, February 18th.

Accuray Trading Down 4.5 %

Shares of ARAY stock opened at $1.92 on Tuesday. The company has a debt-to-equity ratio of 3.51, a quick ratio of 0.88 and a current ratio of 1.62. Accuray Incorporated has a fifty-two week low of $1.40 and a fifty-two week high of $2.95. The company has a market cap of $197.44 million, a PE ratio of -38.40 and a beta of 1.51. The stock’s fifty day moving average price is $2.17 and its two-hundred day moving average price is $2.03.

Accuray (NASDAQ:ARAY) last released its quarterly earnings data on Wednesday, February 5th. The medical equipment provider reported $0.02 earnings per share for the quarter, beating the consensus estimate of ($0.01) by $0.03. Accuray had a negative return on equity of 9.75% and a negative net margin of 0.96%. Equities analysts predict that Accuray Incorporated will post 0.01 EPS for the current fiscal year.

Accuray Company Profile

Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. It offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate.